Literature DB >> 24456237

Food additive carrageenan: Part I: A critical review of carrageenan in vitro studies, potential pitfalls, and implications for human health and safety.

James M McKim1.   

Abstract

Carrageenan (CGN) has been used as a safe food additive for several decades. Confusion over nomenclature, basic CGN chemistry, type of CGN tested, interspecies biology, and misinterpretation of both in vivo and in vitro data has resulted in the dissemination of incorrect information regarding the human safety of CGN. The issue is exacerbated when mechanistic data obtained from in vitro experiments are directly translated to human hazard and used for risk assessment. This can lead to information that is taken out of experimental context and reported as a definitive effect in humans. In recent years, the use of cell-based models has increased and their ability to provide key information regarding chemical or drug safety is well established. In many instances, these new alternative approaches have started to replace the need to use animals altogether. In vitro systems can be extremely useful for understanding subcellular targets and mechanisms of adverse effects. However, care must be exercised when extrapolating the in vitro findings to in vivo effects. Often, issues such as chemical identity and purity, relevant dose, pharmacokinetic properties, solubility, protein binding, adsorption to plastics, and the use of cell models that are biologically and mechanistically relevant are overlooked or ignored. When this occurs, in vitro findings can provide misleading information that is not causally linked to in vivo events in animals or in humans. To date, there has not been a comprehensive review of the CGN in vitro literature, which has reported a wide range of biochemical effects related to this compound. An extensive effort has been made to evaluate as much of this literature as possible. This review focuses on the in vitro observation, the unique chemistry of CGN, and potential pitfalls of in vitro models used for hazard identification. The discussion of the in vitro studies discussed this review are supported by numerous in vivo studies. This provides a unique opportunity to have both the in vitro and in vivo studies reviewed together.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24456237     DOI: 10.3109/10408444.2013.861797

Source DB:  PubMed          Journal:  Crit Rev Toxicol        ISSN: 1040-8444            Impact factor:   5.635


  13 in total

Review 1.  Seaweed Polysaccharide Based Products and Materials: An Assessment on Their Production from a Sustainability Point of View.

Authors:  Nishith A Chudasama; Rosy Alphons Sequeira; Kinjal Moradiya; Kamalesh Prasad
Journal:  Molecules       Date:  2021-04-29       Impact factor: 4.411

2.  Non-clinical safety evaluation of intranasal iota-carrageenan.

Authors:  Alexandra Hebar; Christiane Koller; Jan-Marcus Seifert; Monika Chabicovsky; Angelika Bodenteich; Andreas Bernkop-Schnürch; Andreas Grassauer; Eva Prieschl-Grassauer
Journal:  PLoS One       Date:  2015-04-13       Impact factor: 3.240

3.  The perception of aquaculture on the Swedish West Coast.

Authors:  Jean-Baptiste E Thomas; Jonas Nordström; Emma Risén; Maria E Malmström; Fredrik Gröndahl
Journal:  Ambio       Date:  2017-09-22       Impact factor: 5.129

Review 4.  Algae as nutritional and functional food sources: revisiting our understanding.

Authors:  Mark L Wells; Philippe Potin; James S Craigie; John A Raven; Sabeeha S Merchant; Katherine E Helliwell; Alison G Smith; Mary Ellen Camire; Susan H Brawley
Journal:  J Appl Phycol       Date:  2016-11-21       Impact factor: 3.215

5.  Lambda-Carrageenan Enhances the Effects of Radiation Therapy in Cancer Treatment by Suppressing Cancer Cell Invasion and Metastasis through Racgap1 Inhibition.

Authors:  Ping-Hsiu Wu; Yasuhito Onodera; Frances C Recuenco; Amato J Giaccia; Quynh-Thu Le; Shinichi Shimizu; Hiroki Shirato; Jin-Min Nam
Journal:  Cancers (Basel)       Date:  2019-08-16       Impact factor: 6.575

6.  Effect of Carrageenans on Vegetable Jelly in Humans with Hypercholesterolemia.

Authors:  Ana Valado; Maria Pereira; Armando Caseiro; João P Figueiredo; Helena Loureiro; Carla Almeida; João Cotas; Leonel Pereira
Journal:  Mar Drugs       Date:  2019-12-24       Impact factor: 5.118

7.  Pilot scale isolation of exopolysaccharides from Streptococcus thermophilus DGCC7710: Impact of methodical details on macromolecular properties and technofunctionality.

Authors:  Carsten Nachtigall; Georg Surber; Jannis Bulla; Harald Rohm; Doris Jaros
Journal:  Eng Life Sci       Date:  2020-12-09       Impact factor: 2.678

8.  Immunomodulating Properties of Carrageenan from Tichocarpus crinitus.

Authors:  Eduardas Cicinskas; Aleksandra A Kalitnik; Yuriy A Karetin; Manoj Saravana Guru Mohan Ram; Anant Achary; Anna O Kravchenko
Journal:  Inflammation       Date:  2020-08       Impact factor: 4.657

Review 9.  Oligosaccharides Derived from Red Seaweed: Production, Properties, and Potential Health and Cosmetic Applications.

Authors:  Kit-Leong Cheong; Hua-Mai Qiu; Hong Du; Yang Liu; Bilal Muhammad Khan
Journal:  Molecules       Date:  2018-09-25       Impact factor: 4.411

Review 10.  Current Trends on Seaweeds: Looking at Chemical Composition, Phytopharmacology, and Cosmetic Applications.

Authors:  Bahare Salehi; Javad Sharifi-Rad; Ana M L Seca; Diana C G A Pinto; Izabela Michalak; Antonio Trincone; Abhay Prakash Mishra; Manisha Nigam; Wissam Zam; Natália Martins
Journal:  Molecules       Date:  2019-11-18       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.